Sam Chun Dang Pharm. Co. Ltd.
Clinical trials sponsored by Sam Chun Dang Pharm. Co. Ltd., explained in plain language.
South Korean pharmaceutical company producing prescription and OTC drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could an insulin pill replace the needle for type 1 diabetes? Results expected Oct 2026 (estimated)